EFFECTIVENESS OF GLIATILIN IN THE TREATMENT OF ENCEPHALOPATHY IN CHRONIC KIDNEY DISEASE

Abstract

The problem of encephalopathy in chronic kidney disease is currently the subject of research by many scientists, since it is relevant for almost all countries of the world. The prevalence of stroke and dementia continues to rise. There are currently 47.8 million people with dementia in the world. Its prevalence is expected to double every 20 years.

PDF